Log In
BCIQ
Print this Print this
 

C21

  Manage Alerts
Collapse Summary General Information
Company Vicore Pharma AB
DescriptionAngiotensin II type 2 (AT2) receptor agonist
Molecular Target Angiotensin II type 2 (AT2) receptor (ATGR2)
Mechanism of ActionAngiotensin II type 2 (AT2) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cardiovascular (unspecified)
Indication DetailsRepair damaged cardiac tissue and restore heart function
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today